We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+27.46%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$518M
AUM Growth
+$48.2M
Cap. Flow
-$23.7M
Cap. Flow %
-4.58%
Top 10 Hldgs %
45.83%
Holding
202
New
70
Increased
28
Reduced
29
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$26.4M
2
STKL
SunOpta
STKL
+$23.7M
3
FND icon
Floor & Decor
FND
+$11.5M
4
ABBV icon
AbbVie
ABBV
+$11.4M
5
AMZN icon
Amazon
AMZN
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 16.26%
2 Healthcare 15.06%
3 Consumer Staples 13.72%
4 Industrials 8.5%
5 Communication Services 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JE
126
DELISTED
Just Energy Group Inc
JE
$217K 0.04%
41,633
-38,117
-48% -$440K
FOLD
127
DELISTED
Amicus Therapeutics
FOLD
$212K 0.04%
15,000
-240,000
-94% -$3.5M
QTNT
128
DELISTED
Quotient Limited Ordinary Shares
QTNT
$206K 0.04%
1,000
MP icon
129
MP Materials
MP
$7.35B
$204K 0.04%
+15,000
New +$189K
EW icon
130
Edwards Lifesciences
EW
$49.2B
$200K 0.04%
+2,500
New +$195K
APTO
131
DELISTED
Aptose Biosciences, Inc.
APTO
$179K 0.03%
66
+22
+50% +$54.9K
FLXN
132
DELISTED
Flexion Therapeutics, Inc.
FLXN
$156K 0.03%
15,000
-10,000
-40% -$123K
MYOV
133
DELISTED
Myovant Sciences Ltd.
MYOV
$142K 0.03%
10,100
-9,900
-50% -$184K
MGNI icon
134
Magnite
MGNI
$2.75B
$139K 0.03%
+20,000
New +$134K
ERIC icon
135
Ericsson
ERIC
$32.2B
$109K 0.02%
10,000
-1,000
-9% -$11K
IEAWW
136
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$86K 0.02%
+236,000
New +$48.9K
APEN
137
DELISTED
Apollo Endosurgery, Inc.
APEN
$76K 0.01%
45,188
SEEL
138
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$75K 0.01%
21
BIIB icon
139
Biogen
BIIB
$30.1B
$71K 0.01%
+250
New +$69.7K
RKDA icon
140
Arcadia Biosciences
RKDA
$1.37M
$70K 0.01%
+626
New +$84.5K
ATYR
141
aTyr Pharma
ATYR
$46.8M
$65K 0.01%
+20,000
New +$82.1K
ABEO icon
142
Abeona Therapeutics
ABEO
$357M
$26K 0.01%
1,000
-1,000
-50% -$63K
TBT icon
143
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
$24K ﹤0.01%
+1,500
New +$23.1K
GRDX
144
GridAI Technologies Corp
GRDX
$21.3M
0
VTNR
145
DELISTED
Vertex Energy, Inc
VTNR
$7K ﹤0.01%
17,893
AMAT icon
146
Applied Materials
AMAT
$408B
-11,000
Closed -$665K
API
147
Agora
API
$334M
-25,000
Closed -$1.1M
ATNM icon
148
Actinium Pharmaceuticals
ATNM
$26.4M
-4,333
Closed -$46K
BMRN icon
149
BioMarin Pharmaceuticals
BMRN
$11.5B
-3,000
Closed -$370K
BMY icon
150
Bristol-Myers Squibb
BMY
$131B
-80,500
Closed -$4.73M

Similar funds

Ardsley Advisory Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ardsley Advisory Partners held 202 positions worth $518M, up 10% from $470M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Ardsley Advisory Partners withdrew a net $23.7M in Q3 2020, closing 57 positions and reducing 29 holdings. Its most notable exit was Floor & Decor, an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Ardsley Advisory Partners opened a new position in VanEck Junior Gold Miners ETF worth $14.7M.

  • Ardsley Advisory Partners's largest Q3 2020 buy was VanEck Junior Gold Miners ETF: 265,000 shares worth $14.7M.
  • Ardsley Advisory Partners added most to Centene in Q3 2020, an estimated $4.78M increase.
  • Ardsley Advisory Partners's biggest Q3 2020 reduction was Microsoft, cutting an estimated $26.4M.
  • Ardsley Advisory Partners fully exited Floor & Decor in Q3 2020, selling an estimated $11.5M.
  • Ardsley Advisory Partners's ten largest holdings make up 46% of its $518M portfolio in Q3 2020.
  • Ardsley Advisory Partners opened 70 new positions and closed 57 in Q3 2020.
  • Ardsley Advisory Partners's portfolio value rose 10% quarter-over-quarter to $518M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2020, filed 13 Nov 2020.